Torrent Pharmaceuticals Limited (BOM:500420)

Torrent Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	174,417	139,797	115,161	107,278	96,202	85,080
Revenue Growth	42.40%	21.39%	7.35%	11.51%	13.07%	6.29%
Gross Profit Gross Profit Growth	132,406	105,916	87,402	80,416	68,850	60,660
Operating Income Operating Income Growth	38,998	34,398	29,261	25,724	21,400	17,693
Net Income Net Income Growth	21,244	21,634	19,113	16,564	12,452	7,772
Earnings Per Share EPS Growth	59.12	63.92	56.47	48.94	36.79	22.96
EPS Growth	-6.51%	13.19%	15.39%	33.02%	60.22%	-37.92%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	81,614	67,877	61,094	53,696	46,832
United States United States Growth	13,627	10,998	10,777	11,621	10,672
Germany Germany Growth	12,487	11,394	10,740	9,277	9,663
Brazil Brazil Growth	13,624	11,003	11,261	9,355	7,420
Other Countries Other Countries Growth	18,446	13,889	13,406	12,254	10,493
Total Total Growth	139,797	115,161	107,278	96,202	85,080

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	29,860	23,552	6,880	10,040	7,228	5,830
Total Debt Total Debt Growth	141,070	150,255	32,496	40,394	54,148	41,086
Net Cash (Debt) Net Cash Growth	-111,210	-126,703	-25,616	-30,354	-46,921	-35,257
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-309.49	-374.37	-75.69	-89.69	-138.64	-104.17

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	44,367	30,227	25,851	32,661	23,681	18,030
Capital Expenditures CapEx Growth	-8,704	-6,774	-6,119	-4,328	-5,739	-2,026
Free Cash Flow Free Cash Flow Growth	35,663	23,453	19,732	28,333	17,942	16,004
Free Cash Flow Growth	162.57%	18.86%	-30.35%	57.92%	12.11%	-4.18%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	75.91%	75.76%	75.89%	74.96%	71.57%	71.30%
Operating Margin	22.36%	24.61%	25.41%	23.98%	22.25%	20.80%
Pretax Margin	16.13%	20.55%	23.21%	21.93%	19.20%	14.41%
Profit Margin	12.18%	15.47%	16.60%	15.44%	12.94%	9.13%
FCF Margin	20.45%	16.78%	17.14%	26.41%	18.65%	18.81%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	38.000	38.000	32.000	28.000	22.000	16.500
Dividend Per Share Growth	18.75%	18.75%	14.29%	27.27%	33.33%	-5.71%
Dividend Yield	0.85%	0.90%	0.99%	1.08%	1.43%	1.18%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	75.81	66.03	57.28	53.15	41.78	60.89
Forward PE	55.78	85.72	43.21	43.79	35.81	31.03
P/FCF Ratio	47.80	60.91	55.48	31.07	29.00	29.57
PS Ratio	9.77	10.22	9.51	8.21	5.41	5.56

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error